Implications of personalized medicine--perspective from a cancer center (Q83508020)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21364691%20AND%20SRC:MED&resulttype=core&format=json

24 January 2020

review article

1 reference

title

Implications of personalized medicine--perspective from a cancer center (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21364691%20AND%20SRC:MED&resulttype=core&format=json

24 January 2020

main subject

personalized medicine

1 reference

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21364691%20AND%20SRC:MED&resulttype=core&format=json

24 January 2020

author name string

Thomas Tursz

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21364691%20AND%20SRC:MED&resulttype=core&format=json

24 January 2020

Vladimir Lazar

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21364691%20AND%20SRC:MED&resulttype=core&format=json

24 January 2020

Ludovic Lacroix

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21364691%20AND%20SRC:MED&resulttype=core&format=json

24 January 2020

Jean-Charles Soria

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21364691%20AND%20SRC:MED&resulttype=core&format=json

24 January 2020

publication date

1 March 2011

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21364691%20AND%20SRC:MED&resulttype=core&format=json

Nature Reviews Clinical Oncology

24 January 2020

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21364691%20AND%20SRC:MED&resulttype=core&format=json

24 January 2020

volume

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21364691%20AND%20SRC:MED&resulttype=core&format=json

24 January 2020

issue

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21364691%20AND%20SRC:MED&resulttype=core&format=json

24 January 2020

page(s)

177-183

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21364691%20AND%20SRC:MED&resulttype=core&format=json

Overview of drug discovery and development.

24 January 2020

cites work

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2010.222

Long-term survival of women with breast cancer in New South Wales.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2010.222

Gene expression predictors in breast cancer: current status, limitations and perspectives

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2010.222

Clinical relevance of HER2 overexpression/amplification in patients with small tumor size and node-negative breast cancer

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2010.222

High frequency of mutations of the PIK3CA gene in human cancers

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2010.222

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2010.222

BRCA1 and BRCA2 mutations across race and ethnicity: distribution and clinical implications

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2010.222

RAS and RAF mutations in banal melanocytic aggregates contiguous with primary cutaneous melanoma: clues to melanomagenesis

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2010.222

Hedgehog signaling pathway as a target for therapeutic intervention in basal cell carcinoma.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2010.222

FGFR1 amplification in breast carcinomas: a chromogenic in situ hybridisation analysis

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2010.222

Epidermal growth factor receptor tyrosine kinase inhibitors as first-line treatment in advanced nonsmall-cell lung cancer

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2010.222

Activating mutations in the epidermal growth factor receptor underlying responsiveness of non-small-cell lung cancer to gefitinib

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2010.222

EGFR mutations in lung cancer: correlation with clinical response to gefitinib therapy

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2010.222

EGF receptor gene mutations are common in lung cancers from "never smokers" and are associated with sensitivity of tumors to gefitinib and erlotinib

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2010.222

Mechanisms of acquired resistance to epidermal growth factor receptor tyrosine kinase inhibitors in non-small cell lung cancer

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2010.222

Acquired resistance to epidermal growth factor receptor tyrosine kinase inhibitors in non-small-cell lung cancers dependent on the epidermal growth factor receptor pathway.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2010.222

p95HER-2 predicts worse outcome in patients with HER-2-positive breast cancer

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2010.222

Association between gain-of-function mutations in PIK3CA and resistance to HER2-targeted agents in HER2-amplified breast cancer cell lines

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2010.222

Assessment of somatic k-RAS mutations as a mechanism associated with resistance to EGFR-targeted agents: a systematic review and meta-analysis of studies in advanced non-small-cell lung cancer and metastatic colorectal cancer

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2010.222

An integrative genomic and proteomic analysis of PIK3CA, PTEN, and AKT mutations in breast cancer

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2010.222

Emerging approaches in molecular profiling affecting oncology drug discovery

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2010.222

Determination of oestrogen-receptor status and ERBB2 status of breast carcinoma: a gene-expression profiling study

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2010.222

Molecular characterization of breast cancer with high-resolution oligonucleotide comparative genomic hybridization array.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2010.222

Sequencing technologies - the next generation

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2010.222

Whole-genome cancer analysis as an approach to deeper understanding of tumour biology

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2010.222

A census of human cancer genes

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2010.222

Patterns of somatic mutation in human cancer genomes

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2010.222

DNA sequencing of a cytogenetically normal acute myeloid leukaemia genome

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2010.222

Core signaling pathways in human pancreatic cancers revealed by global genomic analyses

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2010.222

Mutational evolution in a lobular breast tumour profiled at single nucleotide resolution

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2010.222

Detection of oncogenic mutations in the EGFR gene in lung adenocarcinoma with differential sensitivity to EGFR tyrosine kinase inhibitors

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2010.222

Transcriptome sequencing to detect gene fusions in cancer

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2010.222

Transcriptome-guided characterization of genomic rearrangements in a breast cancer cell line

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2010.222

Development of personalized tumor biomarkers using massively parallel sequencing

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2010.222

Tumor transcriptome sequencing reveals allelic expression imbalances associated with copy number alterations

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2010.222

ABL mutations in late chronic phase chronic myeloid leukemia patients with up-front cytogenetic resistance to imatinib are associated with a greater likelihood of progression to blast crisis and shorter survival: a study by the GIMEMA Working Party o

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2010.222

10.1038/NRCLINONC.2010.222

31 March 2020

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21364691%20AND%20SRC:MED&resulttype=core&format=json

24 January 2020

1 reference